1887

Abstract

is an emerging fungal pathogen, especially in immunodeficient patients. We report what is to the best of our knowledge the first case of multifocal osteomyelitis following disseminated infection in a patient after haematopoietic stem cell transplantation. PFGE for typing of was developed and the necessity of long-term antifungal therapy is discussed.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.003970-0
2009-03-01
2019-10-22
Loading full text...

Full text loading...

/deliver/fulltext/jmm/58/3/386.html?itemId=/content/journal/jmm/10.1099/jmm.0.003970-0&mimeType=html&fmt=ahah

References

  1. Dodds Ashley, E. S., Lewis, R., Lewis, J. S., Martin, C. & Andes, C. ( 2006; ). Pharmacology of systemic antifungal agents. Clin Infect Dis 43, S28–S39.[CrossRef]
    [Google Scholar]
  2. Brandt, M. E., Harrison, L. H., Pass, M., Sofair, A. N., Huie, S., Li, R. K., Morrison, C. J., Warnock, D. W. & Hajjeh, R. A. ( 2000; ). Candida dubliniensis fungemia: the first four cases in North America. Emerg Infect Dis 6, 46–49.[CrossRef]
    [Google Scholar]
  3. Carr, M. J., Clarke, S., O'Connell, F., Sullivan, D. J., Coleman, D. C. & O'Connell, B. ( 2005; ). First reported case of endocarditis caused by Candida dubliniensis. J Clin Microbiol 43, 3023–3026.[CrossRef]
    [Google Scholar]
  4. Chan-Tack, K. M. ( 2005; ). Fatal Candida dubliniensis septicemia in a patient with AIDS. Clin Infect Dis 40, 1209–1210.[CrossRef]
    [Google Scholar]
  5. Eraso, E., Sahand, I. H., Villar-Vidal, M., Marcos, C., Dolores, M. M., Madariaga, L., Ponton, J. & Quindos, G. ( 2006; ). Usefulness of Candida ID2 agar for the presumptive identification of Candida dubliniensis. Med Mycol 44, 611–615.[CrossRef]
    [Google Scholar]
  6. Gee, S. F., Joly, S., Soll, D. R., Meis, J. F., Verweij, P. E., Polacheck, I., Sullivan, D. J. & Coleman, D. C. ( 2002; ). Identification of four distinct genotypes of Candida dubliniensis and detection of microevolution in vitro and in vivo. J Clin Microbiol 40, 556–574.[CrossRef]
    [Google Scholar]
  7. Jabra-Rizk, M. A., Johnson, J. K., Forrest, G., Mankes, K., Meiller, T. F. & Venezia, R. A. ( 2005; ). Prevalence of Candida dubliniensis fungemia at a large teaching hospital. Clin Infect Dis 41, 1064–1067.[CrossRef]
    [Google Scholar]
  8. Joly, S., Pujol, C. & Soll, D. R. ( 2002; ). Microevolutionary changes and chromosomal translocations are more frequent at RPS loci in Candida dubliniensis than in Candida albicans. Infect Genet Evol 2, 19–37.[CrossRef]
    [Google Scholar]
  9. Meis, J. F., Ruhnke, M., De Pauw, B. E., Odds, F. C., Siegert, W. & Verweij, P. E. ( 1999; ). Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation. Emerg Infect Dis 5, 150–153.[CrossRef]
    [Google Scholar]
  10. Moran, G. P., Sullivan, D. J., Henman, M. C., McCreary, C. E., Harrington, B. J., Shanley, D. B. & Coleman, D. C. ( 1997; ). Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob Agents Chemother 41, 617–623.
    [Google Scholar]
  11. Nunn, M. A., Schaefer, S. M., Petrou, M. A. & Brown, J. R. ( 2007; ). Environmental source of Candida dubliniensis. Emerg Infect Dis 13, 747–750.[CrossRef]
    [Google Scholar]
  12. Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J. & Edwards, J. E. ( 2004; ). Guidelines for treatment of candidiasis. Clin Infect Dis 38, 161–189.[CrossRef]
    [Google Scholar]
  13. Salgado-Parreno, F. J., Alcoba-Florez, J., Arias, A., Moragues, M. D., Quindos, G., Ponton, J. & Arevalo, M. P. ( 2006; ). In vitro activities of voriconazole and five licensed antifungal agents against Candida dubliniensis: comparison of CLSI M27–A2, Sensititre YeastOne, disk diffusion, and Etest methods. Microb Drug Resist 12, 246–251.[CrossRef]
    [Google Scholar]
  14. Sebti, A., Kiehn, T. E., Perlin, D., Chaturvedi, V., Wong, M., Doney, A., Park, S. & Sepkowitz, K. A. ( 2001; ). Candida dubliniensis at a cancer center. Clin Infect Dis 32, 1034–1038.[CrossRef]
    [Google Scholar]
  15. Sullivan, D. J., Westerneng, T. J., Haynes, K. A., Bennett, D. E. & Coleman, D. C. ( 1995; ). Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 141, 1507–1521.[CrossRef]
    [Google Scholar]
  16. Sullivan, D. J., Moran, G. P., Pinjon, E., Al Mosaid, A., Stokes, C., Vaughan, C. & Coleman, D. C. ( 2004; ). Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans. FEMS Yeast Res 4, 369–376.[CrossRef]
    [Google Scholar]
  17. Sullivan, D. J., Moran, G. P. & Coleman, D. C. ( 2005; ). Candida dubliniensis: ten years on. FEMS Microbiol Lett 253, 9–17.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.003970-0
Loading
/content/journal/jmm/10.1099/jmm.0.003970-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error